FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
ACN Newswire
*TOKYO and CAMBRIDGE, Mass., Jan 28, 2025 - (JCN Newswire) - *Eisai Co., Ltd. and Biogen Inc. announced today that the U.S. Food..